Birch Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Birch Financial Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Sell	993 -66	-6%	-$15.4K	0.14%	111
2026 Q1	$242K	Buy	1,059 +9	+0.9%	+$2.02K	0.14%	115
2025 Q4	$224K	Sell	1,050 -247	-19%	-$51K	0.13%	123
2025 Q3	$258K	Sell	1,297 -60	-4%	-$11.2K	0.15%	100
2025 Q2	$234K	Sell	1,357 -138	-9%	-$22.5K	0.19%	99
2025 Q1	$233K	Sell	1,495 -44	-3%	-$6.29K	0.21%	90
2024 Q4	$212K	Buy	+1,539	New	+$202K	0.24%	80

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Birch Financial Group's ASND Position: Q2 2026 in Review

Birch Financial Group reduced its Ascendis Pharma A/S (ASND) stake by 6.2% in Q2 2026, selling an estimated $15.4K and leaving 993 shares worth $265K. The position accounts for 0.14% of the portfolio, ranked #111.

Birch Financial Group first reported a position in ASND in Q4 2024 and has held it in 7 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Birch Financial Group held 993 shares of Ascendis Pharma A/S worth $265K as of Q2 2026.
Birch Financial Group sold 66 Ascendis Pharma A/S shares in Q2 2026, an estimated $15.4K.
Ascendis Pharma A/S made up 0.14% of Birch Financial Group's portfolio in Q2 2026, its #111 holding.
Birch Financial Group first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 7 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Birch Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.